omega-n-methylarginine has been researched along with tromethamine in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tromethamine) | Trials (tromethamine) | Recent Studies (post-2010) (tromethamine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 3,651 | 284 | 447 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billiar, TR; Pastor, CM | 1 |
1 other study(ies) available for omega-n-methylarginine and tromethamine
| Article | Year |
|---|---|
Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats.
Topics: Animals; Arginine; Blood Pressure; Endotoxins; Escherichia coli; Glucose; In Vitro Techniques; Liver; Male; Nitric Oxide; omega-N-Methylarginine; Penicillamine; Perfusion; Phenylephrine; Portal System; Rats; Rats, Sprague-Dawley; Regional Blood Flow; S-Nitroso-N-Acetylpenicillamine; Tromethamine; Vasoconstriction; Vasodilator Agents | 1995 |